Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fecal calprotectin measurement as a biomarker of severe disease phenotype in celiac disease and non-celiac enteropathies.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Jan 2025

Schiepatti Annalisa, Cappellini Alessandro, Maimaris Stiliano, Minerba Paolo, Retrosi Martina, Mantica Giulia, Scarcella Chiara, Delogu Claudia, Arpa Giovanni, Bianchi Paola Ilaria, Di Sabatino Antonio, Biagi Federico

Abstract excerpt

BACKGROUND: Fecal calprotectin (FC) is a non-invasive biomarker of gut inflammation, but its role in celiac disease (CD) and non-celiac enteropathies (NCEs) is undefined. AIMS: To retrospectively evaluate FC in patients with CD and NCEs as a tool for assessing disease activity and predicting long-term outcomes. METHODS: Patients with uncomplicated and complicated CD, and NCEs with data on FC, evaluated at our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Celiac Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukocyte L1 Antigen Complex

Share to Phenotype

Share to Proportional Hazards Models

Share to Severity of Illness Index

Source

Identifiers

PMID: 39370353
DOI: 10.1016/j.dld.2024.09.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fecal calprotectin measurement as a biomarker of severe disease phenotype in celiac disease and non-celiac enteropathies.PMID 39370353Read ↗

Fecal calprotectin: beyond intestinal organic diseases.Semantic proximity Read ↗

Clinical, Serological and Histopathological Characteristics of Patients with Celiac Disease in Yemen: A Multicenter Retrospective StudySemantic proximity Read ↗

The utility of capsule endoscopy in the phenotype of Crohn's disease. Data from England 2016-2021.Semantic proximity Read ↗

Celiac disease biomarkers identified by transcriptome analysis of small intestinal biopsiesSemantic proximity Read ↗

Guidelines for best practices in monitoring established coeliac disease in adult patients.Semantic proximity Read ↗

Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individualsSemantic proximity Read ↗

Preclinical Serological Signatures are Associated With Complicated Crohn's Disease Phenotype at Diagnosis.Semantic proximity Read ↗

Histopathological Correlation in Suspected Celiac Disease: Linking Clinical, Serological, and Endoscopic FindingsSemantic proximity Read ↗

Retrospective analysis of celiac disease in Yemen: Results of a multicenter screening between 2020 and 2024Semantic proximity Read ↗

BMI Status of Children with Celiac Disease Has Changed in the Last Decades: A 30-Year Retrospective StudySemantic proximity Read ↗

Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn's Disease.Semantic proximity Read ↗

Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.